Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells
Philip E. Brandish, Mark Zielstorff(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mark T. Cancilla, Anthony Palmieri, Prasanthi Geda, Peter Stivers, Isabel Figueroa(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lily Y. Moy(Merck & Co., Inc., Rahway, NJ, USA (United States)), Laurence Fayadat‐Dilman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jeffrey C. Kern, Nickolas Knudsen(Torrey Pines Institute For Molecular Studies), Douglas Hodges(Merck & Co., Inc., Rahway, NJ, USA (United States)), Paul L. Miller(Merck & Co., Inc., Rahway, NJ, USA (United States)), Huiping Ma(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mangeng Cheng, Shuli Zhang(First Affiliated Hospital of Xinjiang Medical University), Kristen Kwasnjuk, Anthony Manibusan(Ambrx (United States)), R. M. Garbaccio(Merck & Co., Inc., Rahway, NJ, USA (United States)), Daniela M. Tomazela(Merck & Co., Inc., Rahway, NJ, USA (United States)), Juhi Firdos(Ambrx (United States)), SuChun Hseih(Merck & Co., Inc., Rahway, NJ, USA (United States)), Hyun Chong Woo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Maribel Beaumont(Merck & Co., Inc., Rahway, NJ, USA (United States)), L Benso(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yujie Qu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Guo Feng, Linda Liang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Laura Garvin-Queen(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yiwei Zhang(Nanjing Forestry University), John Shin(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dennis M. Zaller(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ying Sun(Torrey Pines Institute For Molecular Studies), Dennis Gately(Ambrx (United States)), Christopher J. Haines(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sanjiv Shah, S. V. Antonenko(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 58
Related Papers
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
|Proceedings of the National Academy of Sciences|2008|723
The importance of synthetic chemistry in the pharmaceutical industry
|Science|2019|650
CC-1065 and the Duocarmycins: Synthetic Studies
|Chemical Reviews|1997|267
A Transgenic Model to Analyze the Immunoregulatory Role of IL-10 Secreted by Antigen-Presenting Cells
|The Journal of Immunology|1999|248